SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000898430-01-501477
Filing Date
2001-07-27
Accepted
2001-07-27 00:00:00
Documents
6
Period of Report
2001-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.txt 10-Q 64900
2 AGREEMENT BETWEEN AMGEN & BRIAN MCNAMEE dex1049.txt EX-10.49 19337
3 AGREEMENT BETWEEN AMGEN & RICHARD NANULA dex1050.txt EX-10.50 11740
4 PROMISSORY NOTE OF RICHARD NANULA dex1051.txt EX-10.51 6648
5 PROMISSORY NOTE OF ROGER PERLMUTTER dex1052.txt EX-10.52 10488
6 FACTORS THAT MAY AFFECT AMGEN dex99.txt EX-99 19334
  Complete submission text file 0000898430-01-501477.txt   134679
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-12477 | Film No.: 1690993
SIC: 2836 Biological Products, (No Diagnostic Substances)